A step further with ivabradine: SIGN I f Y ( S tudy assess I n G the morbiditymortality be N efits of the I f inhibitor ivabradine in patients with coronar Y artery disease)

Author： Ferrari Roberto  

Publisher： Oxford University Press

ISSN： 1520-765X

Source： European Heart Journal Supplements, Vol.11, Iss.1, 2009-08, pp. : 19-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coronary artery disease management with ivabradine in clinical practice

By Pinto Fausto J.  

European Heart Journal Supplements, Vol. 13, Iss. 1, 2011-09 ,pp. : 25-29

Oxford University Press

Access to resources Recommend Favorite

PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease

By Anvari A.   Schuster E.   Gottsauner-Wolf M.   Wojta J.   Huber K.  

Thrombosis Research, Vol. 103, Iss. 2, 2001-07 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

Synaptosomal Proteins, Beta-Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein (Beta-SNAP), Gamma-SNAP and Synaptotagmin I in Brain of Patients with Down Syndrome and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 3, 2001-03 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

Ivabradine: a Selective If Current Inhibitor in the Treatment of Stable Angina

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 277-282

Bentham Science Publishers

Access to resources Recommend Favorite

Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 1, 2015-01 ,pp. : 4-9

Bentham Science Publishers

Access to resources Recommend Favorite